普洛药业(000739) - 2015 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 9.18% to CNY 46,630,328.14 for the current period[7] - Operating revenue for the current period was CNY 1,105,681,642.33, a decline of 2.09% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 17.02% to CNY 53,006,644.10[7] - Basic earnings per share rose by 20.77% to CNY 0.0407 for the current period[7] - The weighted average return on equity was 1.94%, a decrease of 0.27% compared to the previous year[7] - Cash flow from operating activities decreased by 48.51% to CNY 219,614,502.92 year-to-date[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 84,110[11] - The largest shareholder, Hengdian Group Holdings Co., Ltd., held 23.52% of the shares[11] Non-Recurring Gains and Losses - The company reported a total of CNY 13,639,876.22 in non-recurring gains and losses for the year-to-date[8] Asset Changes - Total assets increased by 8.01% to CNY 5,467,353,613.50 compared to the end of the previous year[7] - Accounts receivable increased by 72.87% to 132,164,942.02 from 76,453,805.39 due to increased billings[15] - Prepayments rose by 65.65% to 85,832,777.92 from 51,814,402.51, attributed to increased advance payments for projects[15] - Long-term equity investments surged by 5822.94% to 29,374,266.36 from 495,940.47, reflecting the addition of a new joint venture[15] - Inventory increased by 36.01% to 795,819,074.26 from 585,118,844.86, indicating a rise in stock levels[15] - Other current assets grew by 37.39% to 80,359,409.64 from 58,489,176.15, primarily due to an increase in deductible input tax[15] Cash Flow and Payments - Cash received from the disposal of fixed assets, intangible assets, and other long-term assets netted 26,264,647.23, a 364.47% increase from 5,654,813.26[15] - Cash paid for dividends, profits, and interest increased by 81.11% to 137,484,624.74 from 75,911,976.94, reflecting higher dividend payouts[15] - The company reported a 49.13% decrease in cash used for debt repayment, totaling 717,692,738.76 compared to 1,410,932,950.87 in the previous period[15] - The fair value change of financial liabilities decreased by 55.18%, with trading financial liabilities at 4,590,000.00 down from 10,240,281.83[15] Commitments - The company has ongoing commitments related to asset restructuring and management standardization, with commitments made in 2012 still being fulfilled[16]